Koyfin Home > Directory > Health Care > Nanostring Tech > Capital Expenditures

Nanostring Tech Capital Expenditures Chart (NSTG)

Nanostring Tech annual/quarterly Capital Expenditures from 2011 to 2020.
  • Nanostring Tech Capital Expenditures for the quarter ending June 06, 2020 was $-1m a 51.96% decrease of -1m year over year
  • Nanostring Tech Capital Expenditures for the last 12 months ending June 06, 2020 was $-12m a 71.40% decrease of -9m year over year
  • Nanostring Tech Annual Capital Expenditures for 2019 was $-8m a 43.12% decrease of -3m from 2018
  • Nanostring Tech Annual Capital Expenditures for 2018 was $-4m a 4.48% decrease of 0m from 2017
  • Nanostring Tech Annual Capital Expenditures for 2017 was $-4m a 6.84% decrease of 0m from 2016
Other Cash Flow Metrics:
  • Nanostring Tech Cash Flow from Operations for the quarter ending September 09, 2018 was $-11m a -9.07% increase of 1m year over year
  • Nanostring Tech Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-9m a 25.27% decrease of -2m year over year
  • Nanostring Tech Total Revenue for the quarter ending September 09, 2018 was $29m a -23.12% decrease of -7m year over year
View Chart On Koyfin

Quarterly NSTG Capital Expenditures Data

06/2020$-1m
03/2020$-4m
12/2019$-6m
09/2019$-1m
06/2019$-1m
03/2019$0m
12/2018$-2m
09/2018$-1m
06/2018$-1m
03/2018$-1m

Annual NSTG Capital Expenditures Data

2019$-8m
2018$-4m
2017$-4m
2016$-4m
2015$-4m
2014$-2m
2013$-1m
2012$0m
2011$-3m
2010$-2m